Tuesday, December 5, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Exact Sciences
Supported by an independent educational grant from
Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC
Supported by an independent educational grant from
Novartis Oncology
Supported by an independent educational grant from
Regeneron Pharmaceuticals, Inc.
Supported by an independent educational grant from
Sanofi
Steering Committee Conference Chair
Landry Family Professor of Medicine
Harvard Medical School
Director, Center for Innovation in Early Cancer Detection
Massachusetts General Hospital
Boston, Massachusetts
Steering Committee Conference Co-Chair
Leslye M. Heisler Associate Professor of Lung Cancer Excellence
Director, Precision Oncology Innovation, Penn Center for Cancer Care Innovation (PC3I)
Associate Director, Penn Center for Precision Medicine Physician Leader, Airways Malignancies Clinical Research
University of Pennsylvania
Philadelphia, Pennsylvania
Steering Committee Conference Co-Chair
Assistant Professor of Medicine
Harvard Medical School
Thoracic Oncologist
Internal Medicine/Medical Oncology
Massachusetts General Hospital
Boston, Massachusetts
Steering Committee Conference Co-Chair
Associate Professor of Medicine
Director, Thoracic Medical Oncology Program
Department of Hematology and Medical Oncology
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia
Steering Committee Conference Co-Chair
Associate Professor of Medicine
Director of Thoracic Oncology
Director of Developmental Therapeutics
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC
Steering Committee Conference Co-Chair
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Deputy Associate Director for Clinical Research
Case Comprehensive Cancer Cente
Medical Oncologist, Department of Hematology and Oncology
Taussig Cancer Center, Cleveland Clinic
Cleveland, Ohio
Steering Committee Conference Co-Chair
Assistant Professor of Medicine
Harvard Medical School
Massachusetts General Hospital
Boston, Massachusetts
Steering Committee Member
Professor of Pathology
Medical Director, Colorado Molecular Correlates Laboratory (CMOCO)
University of Colorado
Aurora, Colorado
Steering Committee Member
Assistant Professor of Medicine
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia
Steering Committee Member
Assistant Professor
Thoracic Head and Neck Medical Oncology
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Steering Committee Member
Assistant Professor of Radiation Oncology
Cancer Biology Division, Genetics
Biomedical Engineering and Computer Science & Engineering
Washington University School of Medicine
St Louis, Missouri
Steering Committee Member
Professor of Pathology
Vice Chair and Director of Anatomic Pathology
Yale School of Medicine
New Haven, Connecticut
Steering Committee Member
Assistant Professor
Thoracic Oncology | Novel Therapeutics
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York
Steering Committee Member
Professor of Medicine
Hematology and Oncology
Department of Medicine
University of Chicago
Chicago, Illinois
Steering Committee Member
Associate Professor
The University of Texas Southwestern Medical Center
Chief of Lung Radiation Oncology Service
Vice Chair, Strategy & Program Development
Dallas, Texas
Steering Committee Member
Assistant Professor
Department of Radiation and Cellular Oncology
University of Chicago
Chicago, Illinois
Steering Committee Member
Associate Professor of Oncology
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital
Baltimore, Maryland
Steering Committee Member
Assistant Professor
Division of Hematology/Oncology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Steering Committee Member
Assistant Professor, Oncology
Associate Program Director, Hematology/Medical Oncology Fellowship Program
Johns Hopkins University School of Medicine
Baltimore, Maryland
Steering Committee Member
Hematology and Medical Oncology
The Cleveland Clinic
Cleveland, Ohio
Steering Committee Member
Clinical Assistant Professor
Medical Oncology, Internal Medicine
University of Michigan Health
Brighton, Michigan
Steering Committee Member
Assistant Professor
Thoracic and Medical Oncology
Department of Medicine
Georgetown University Medical Center
Washington, DC
Steering Committee Member
Assistant Professor of Clinical Medicine
Division of Hematology/Oncology
Associate Member, Experimental and Developmental Therapeutics
Indiana University School of Medicine
Indiana University Health Physicians
Indianapolis, Indiana
Steering Committee Member
Assistant Professor
Department of Medicine
NYU Grossman School of Medicine
New York, New York
Steering Committee Member
Vice-President Academic Affairs
Professor, Department of Thoracic/Head and Neck Medical Oncology
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Steering Committee Member
Associate Attending
Section Head, Molecular Targets in Lung Cancer
Memorial Sloan Kettering Cancer Center
New York, New York
Steering Committee Conference Chair
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Genentech; Janssen; Pfizer, Inc.; Takeda
Research funding from: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech; Novartis
Steering Committee Conference Co-Chair
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; BeiGene (Beijing) Co., Ltd; Blueprint Genetics; Boehringer Ingelheim Pharmaceuticals, Inc.; Celgene Corporation; Daiichi Sankyo, Inc.; Eisai, Inc.; Genentech; Janssen; Lilly; Merck; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi; Shionogi & Co., Ltd.; Turning Point Therapeutics
Research funding from: AstraZeneca; Genentech; Incyte Corporation; Macrogenics; MedImmune Inc.; Merck Sharp & Dohme; Roche
Steering Committee Conference Co-Chair
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Bayer; Bristol Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; BostonGene; Genentech; Janssen; Novocure; Pfizer, Inc.; Sanofi/Genzyme; Syros; Xcovery Vision
Speaker or member of speakers bureau for: Aptitude Health; DAVA Oncology
Research funding from: Array BioPharma; Genentech; Novartis; Pfizer, Inc.; Vivace
Steering Committee Conference Co-Chair
The opinions expressed are those of Dr Leal and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Leal's participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
Has the following relevant financial relationships:
Consultant or advisor for: Amgen, Inc.; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Eisai, Inc.; EMD Serono, Inc.; Genentech; Janssen; Jazz Pharmaceuticals, Inc.; Lilly; Merck; Mirati Therapeutics, Inc.; Novocure; Roche; Takeda
Steering Committee Conference Co-Chair
Has the following relevant financial relationships:
Consultant or advisor for: Amgen, Inc.; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb Company; Catalyst Pharmaceutical Partners, Inc.; Daiichi Sankyo, Inc.; Eisai, Inc.; Elevation Oncology; Genentech; Gilead Sciences, Inc.; Guardant Health, Inc.; Janssen; Jazz Pharmaceuticals, Inc.; Lilly; Merck; Merck Sharp & Dohme; Novartis; Regeneron Pharmaceuticals, Inc.; Roche; Sanofi; Takeda; Turning Point Therapeutics
Research funding from: Alkermes, Inc.; Bayer; Blueprint Medicines; Bristol Myers Squibb Company; Elevation Oncology; Genentech; Gilead Sciences, Inc.; Merck; Merus; Nuvalent; Pfizer, Inc.; RAPT Therapeutics; Turning Point Therapeutics
Steering Committee Conference Co-Chair
Has the following relevant financial relationships:
Consultant or advisor for: Genentech; Janssen; Lilly; Loxo Oncology; Merck; Mirati Therapeutics, Inc; Novartis; Pfizer, Inc.; ResistanceBio; Sanofi Genzyme
Research funding from: Altor; AstraZeneca; Genentech; Heat Biologics; Jounce Therapeutics; Loxo Oncology; Merck; Mirati Therapeutics, Inc.; Navire Pharma; Sanofi; Spectrum Pharmaceuticals; WindMIL Therapeutics
Steering Committee Conference Co-Chair
Has the following relevant financial relationships:
Consultant or advisor for: Blueprint Medicines; C4 Therapeutics; Cullinan Oncology; Daiichi Sankyo, Inc.; Janssen; Jazz Pharmaceuticals; Lilly; Takeda
Research funding from: AbbVie, Inc.; AstraZeneca; Blueprint Medicines; Cullinan Oncology; Daiichi Sankyo, Inc.; GlaxoSmithKline; Janssen; Novartis; Spectrum Pharmaceuticals; Takeda; Tesaro, Inc.
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AbbVie, Inc.; AstraZeneca; Bristol Myers Squibb Company; Genentech; Loxo Oncology; Sanofi Genzyme; Takeda
Research funding from: Genentech
Steering Committee Member
The opinions expressed are those of Dr Carlisle and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Carlisle's participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
Has no relevant financial relationships.
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Arrowhead Pharmaceuticals, Inc.; AstraZeneca; Bristol Myers Squibb Company; EMD Serono, Inc.; Genentech; MedImmune, Inc.; Merck & Co., Inc.; Regeneron Pharmaceuticals, Inc.
Research funding from: AstraZeneca; Bristol Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; EMD Serono, Inc.; MedImmune, Inc.
Contracted researcher for: AstraZeneca; Bristol Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; EMD Serono, Inc.; MedImmune, Inc.
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AlphaSights; AstraZeneca; Daiichi Sankyo, Inc.; DeciBio; Geneoscopy; Guidepoint; Illumina; Roche; Tempus Labs, Inc.
Patent beneficiary of: Biocognitive Labs; Droplet Biosciences; LiquidCell Dx; Tempus Labs, Inc.
Stock options from: Geneoscopy
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AbbVie, Inc.; AstraZeneca; Genentech; Merck; Takeda
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca (former); Dedham Group; Mirati Therapeutics, Inc. (former)
Steering Committee Member
Has no relevant financial relationships.
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca
Research funding from: Incyte Corporation
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Aqualung Therapeutics; GE Healthcare; Isoray
Research funding from: AstraZeneca
Steering Committee Member
Participation by Dr Levy does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.
Has the following relevant financial relationships:
Consultant or advisor for: Amgen, Inc.; AstraZeneca; Daiichi Sankyo, Inc.; Genentech; Guardant Health, Inc.; Janssen; Lilly; Mirati Therapeutics, Inc.; Novartis; Pfizer, Inc.; Roche
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Blueprint Pharmaceuticals (former); Bristol Myers Squibb Company (former); Boehringer Ingelheim Pharmaceuticals, Inc.; Ikena Oncology; Janssen (former); Novocure (former); Takeda (former); Thermo Fisher Scientific Inc.
Research funding from: AstraZeneca; Lilly; Merck; Trizell
Owns stock (publicly traded) in: bluebird bio, Inc.; Gilead Sciences, Inc.; Merck; Novartis; Pfizer, Inc.; Portola Pharmaceuticals, Inc.
Other: Medical Writing Support for Novartis
Steering Committee Member
Participation by Dr Marrone does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.
Has the following following relevant financial relationships:
Consultant or advisor for: Daiichi Sankyo, Inc.; Janssen; Mirati Therapeutics, Inc.; Puma Biotechnology; Regeneron Pharmaceuticals, Inc.
Research funding from: Bristol Myers Squibb Company; Mirati Therapeutics, Inc.
Steering Committee Member
Has no relevant financial relationships.
Steering Committee Member
Has the following relevant financial relationships:
Research funding from: Ascentage Pharma; AstraZeneca; Clovis Oncology; Merck; Xencor, Inc.
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Genentech; Guardant Health, Inc.; Personalis; Oncocyte; Roche; Sanofi/Genzyme
Speaker or member of speakers bureau for: AstraZeneca; Merck
Research funding from: Genentech; Roche; Verastem, Inc.
Steering Committee Member
Has no relevant financial relationships.
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Blueprint Medicines; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech; Gilead Sciences, Inc.; Janssen
Research funding from: Delfi Diagnostics
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Ariad Pharmaceuticals, Inc.; AstraZeneca; Bristol Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; EMD Serono, Inc.; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer, Inc.; Roche; Seagen Inc.
Research funding from: Ariad Pharmaceuticals, Inc.; AstraZeneca; Bristol Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Epizyme, Inc.; Genentech; Lilly; Merck; Millennium; Novartis; Polaris Group; Seagen Inc.
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Black Diamond Therapeutics; Blueprint Medicines; Cullinan Oncology; Daiichi Sankyo, Inc.; Janssen; Taiho Pharmaceutical Co., Ltd.
Research funding from: AstraZeneca; Black Diamond Therapeutics; Blueprint Medicines; Cullinan Oncology; Daiichi Sankyo, Inc.; Erasca, Inc.; Janssen; Novartis; Pfizer, Inc.
